Research Peptide Quality & Purity Testing

Our documentation standard

North Summit Labs supplies lyophilized research peptides for in-vitro laboratory work. Our quality position is deliberately narrow: for every lot we list, we obtain analytical testing from an independent laboratory and publish or supply the resulting Certificate of Analysis tied to that lot number. We do not perform our own analysis, and we do not describe capabilities we do not have.

That means the value of our documentation comes from a third party. The issuing laboratory is named on each certificate so a researcher can evaluate the source directly rather than taking a supplier's word for a purity figure.

Independent third-party analysis

Each lot we offer is sampled and submitted to an outside analytical laboratory. Methods vary by compound and by laboratory, and the certificate for each lot states which methods were actually run. Across our current catalog, the methods represented include:

• RP-HPLC purity determination — reverse-phase chromatographic separation with peak-area quantification of the target compound.
• Mass spectrometry identity confirmation — comparison of observed molecular mass against the theoretical mass of the intended sequence.
• Content / quantitation assays — where the issuing laboratory reports peptide content per vial for that lot.

The specific laboratory, method set, and result values for each currently listed lot are visible in the North Summit Labs COA library. If you want the background on how to interpret those documents, start with our guide to what a peptide Certificate of Analysis contains.

What HPLC purity testing actually measures

High-performance liquid chromatography pushes a dissolved sample through a packed column under pressure. Components travel at different rates depending on their affinity for the stationary phase, so they exit the column separated in time. A detector — commonly UV absorbance in the 210–220 nm range for peptide bonds — records each component as a peak.

Purity is then reported as the target peak's area divided by the total detected peak area, expressed as a percentage. A result of 99.5% means that under that laboratory's conditions, 99.5% of the detected signal corresponded to the target compound. It does not mean the remaining 0.5% has been identified, and it does not account for anything the detector cannot see.

This is why chromatographic purity is a comparative, method-dependent figure. Two laboratories running different gradients, columns, or detection wavelengths can legitimately report slightly different numbers for the same material. Our longer explanation lives in what analytical purity actually means.

What mass spectrometry peptide testing measures

Mass spectrometry ionizes the sample and measures mass-to-charge ratios, producing an observed molecular weight. For a synthetic peptide, the observed mass is compared against the theoretical mass calculated from the intended amino acid sequence. Agreement within the instrument's expected tolerance supports correct identity; a mismatch indicates a different molecule, a modification, or a truncation product.

Identity and purity answer different questions. Mass spectrometry says "this is the right molecule." HPLC says "and this is how much of the sample it accounts for." A credible peptide COA generally addresses both.

Lot and batch identification

Every certificate is tied to a lot number, and that lot number appears on the vial label. Traceability is the mechanism that makes documentation meaningful: without a matching lot identifier, a purity figure describes some other material. If the lot on your vial does not match a published certificate, request the correct one rather than assuming equivalence. Background reading: lot and batch traceability for research peptides.

What we do not claim

Being explicit about the limits of our documentation is part of the standard:

• We do not hold or claim laboratory accreditation of our own.
• We do not claim sterility, endotoxin, bioburden, or heavy-metal testing unless a specific lot's certificate reports that specific test.
• We do not claim GMP manufacturing status.
• We do not represent analytical results as evidence of safety, efficacy, or fitness for any purpose.
• We make no medical, therapeutic, diagnostic, or dosing claims of any kind. See the FDA disclaimer.

Handling and storage after delivery

Analytical quality at the point of testing can be undone by poor handling afterward. Lyophilized material is sensitive to moisture, temperature excursions, light, and repeated freeze-thaw cycles. Our laboratory peptide storage guide covers general handling principles for research settings.

Frequently asked questions about peptide testing